Table 2.
Description of neonatal adverse outcomes for a cohort of children with cystic fibrosis (CF present) compared to birth-year matched children without CF (CF absent) in Washington State from 1996- 2013 and 2006-20131
| 1996-2013 | 2006-2013 | |||||||
|---|---|---|---|---|---|---|---|---|
| CF Present (N=170) | CF Absent (N=3400) | CF Present (N=68) | CF Absent (N=1360) | |||||
| Low Birth Weight (<2500 grams), n (%) | 32 | (18.8) | 201 | (5.9) | 17 | (25.0) | 92 | (6.8) |
| Small for Gestational Age2 (<10th percentile), n (%) | 23 | (13.5) | 286 | (8.4) | 5 | (7.4) | 109 | (8.0) |
| Pre-term Birth (<37 weeks), n (%) | 41 | (24.1) | 288 | (8.5) | 19 | (27.9) | 140 | (10.3) |
| Infant Death3 (Death <1 year), n (%) | 3 | (1.8) | 11 | (0.3) | 3 | (4.4) | 5 | (0.4) |
1
<1% missing data unless otherwise noted
2
SGA missing for 1.2% of children with CF present (1996-2013), and for 3.8% of children with CF absent (1996-2013); SGA missing for 2.9% of children with CF present (2006-2013), and for 2.9% of children with CF absent (2006-2013)
3
Infant death among infants with CF present occurred in 2 infants without meconium ileus and 1 infant with meconium ileus
CF=cystic fibrosis, SGA=small for gestational age